Nationally recognized!

Recently, after the recommendation of various provincial adverse drug reaction monitoring institutions and the comprehensive evaluation of the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO.,LTD.JS has outstanding performance in fulfilling its main responsibility in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.

The achievement of the results fully reflects the affirmation of the preliminary work of Ab&B Bio-Tech CO.,LTD.JS by adverse drug reaction monitoring institutions at all levels, and Ab&B Bio will cherish the honor, continue to implement the "four strictest" requirements and the spirit of General Secretary Xi Jinping's series of important instructions on drug safety work, and perform their duties with a stronger sense of responsibility and mission, improve their pharmacovigilance ability, and contribute to the protection of public health!